Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sodium-dependent dopamine transporter (DAT/SLC6A3) is an essential regulator of dopaminergic neurotransmission through high-affinity uptake mechanisms tightly coupled with sodium gradients at neuronal membranes. It plays critical roles not only under normal physiological conditions but also as a key target for multiple neuropsychiatric medications—and its dysfunction contributes directly to several major brain diseases including ADHD, Parkinson’s disease, bipolar disorder, substance abuse syndromes among others.
Inhibition of dopamine reuptake; Induction of reverse transport (efflux)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent Dopamine Transporter (DAT).